The content on this page was provided by an independent third party and syndicated by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.
KFSHRC Board Approves Extension of Dr. Björn Zoëga’s Appointment as Chief Executive Officer – Riyadh
Distributed by EIN Presswire
RIYADH, SAUDI ARABIA, January 19, 2026 /EINPresswire.com/ — The Board of Directors of King Faisal Specialist Hospital & Research Centre (KFSHRC) has approved the extension of Dr. Björn Zoëga’s appointment as Chief Executive Officer – Riyadh through 2030.
Since assuming the role, Dr. Zoëga has played a central role in strengthening KFSHRC’s Centers of Excellence model and advancing organizational efficiency across its clinical, educational, and research functions. Under his leadership, the hospital has continued to enhance its operational performance, academic impact, and global standing as a leading tertiary and quaternary care institution.
These efforts have further reinforced KFSHRC’s position among the world’s foremost healthcare and research centers, supporting its long-term mandate to deliver world-class healthcare outcomes and sustainable institutional excellence.
The Board’s decision reflects its strong confidence in Dr. Zoëga’s leadership and in the executive team’s collective ability to advance KFSHRC’s strategic priorities and long-term ambitions.
KFSHRC ranks first in the Middle East and Africa and fifteenth globally among the world’s top 250 academic medical centers for 2025. It also holds the highest valued healthcare brand in Saudi Arabia and the region, according to Brand Finance 2024, and is listed by Newsweek among the World’s Best Hospitals 2025, the World’s Best Smart Hospitals 2026, and the World’s Best Specialized Hospitals 2026.
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media